Beruflich Dokumente
Kultur Dokumente
BANGALORE, KARNATAKA.
ANNEXURE - II
PROFORMA FOR REGISTRATION OF SUBJECTS FOR DISSERTATION
1.
Name
of
the
Candidate
POSTGRADUATE IN E.N.T,
DEPARTMENT OF E.N.T,
S. NIJALINGAPPA MEDICAL COLLEGE
& H. S. K HOSPITAL & RESEARCH
CENTRE, NAVANAGAR, BAGALKOT
2.
587102, KARNATAKA.
S. NIJALINGAPPA MEDICAL COLLEGE
587102, KARNATAKA.
M.S. (E.N.T) [3 YEARS]
31/05/2011.
RANDOMIZED COMPARATIVE STUDY
TO
EVALUATE
HYPERTONIC
ISOTONIC
EFFICACY
SALINE
SALINE
OF
AGAINST
IN
THE
6.
6.2
Review of Literature:
In a person having a painful spot in the head with intense headache,
pus or fluid running from the nose removes the disease said Hippocrates in
5th century B.C., referring to sinus infection.
Prospects for ancillary treatment of chronic sinusitis was revived in
19th century. Wingrave in 1902 discussed cleansing of the nasal passages as an
important method of treating different illnesses of nose and paranasal sinuses.1
Nasal irrigation has been advocated since Vedic times. In Hatha Yoga,
Jala-neti is described as a nasal cleansing technique for sinonasal disease.2
Shoseyov D et al. in 1998 studied 34 children in the age group of 3 to
16 years with chronic maxillary sinusitis. Males constituted 53.33% of the
study group. Each individual was treated with either hypertonic saline or
normal saline nasal drops for a period of 4 weeks and noticed a compliance of
88.24%. Discontinuation of the treatment was due to burning sensation in the
nose and throat in 8.82% of hypertonic saline group and 2.94% of the normal
saline group. Hypertonic saline group showed improvement in cough score
from 3.60.51 to 1.640.74, nasal secretion /PND score from 2.860.35 to
1.60.74 and radiological score from 8.061.28 to 2.661.04. The normal
3
saline treatment group showed significant improvement only in the PND score
from 2.660.49 to 1.530.83 but no significant change in cough score (from
3.530.52 to 3.330.49) and radiological score (from 8.131.25 to 7.860.91).
In this study hypertonic saline group improved significantly in clinical and
radiological scores.3
Study conducted by Tomooka LT et al. of USA in July 2000 revealed
that nasal irrigation was effective in improving symptoms and health status of
patients with sinonasal disease. Study was conducted on 211 patients and 20
disease free control subjects. Patients irrigated their nasal cavities using
hypertonic saline delivered by a waterpik
available nasal adapter twice daily for 3 to 6 weeks. Patients rated nasal disease
specific symptoms and completed a self-administered quality of well being
questionnaire before intervention and at follow-up. 76% of patients reported
symptomatic improvement and 24% reported adverse side effects or no
beneficial effects from nasal irrigation. Adverse side effects included nasal
irritation, nasal discomfort, otalgia and pooling of saline in paranasal sinuses
with subsequent drainage. Compliance reported after 6 weeks was 92% among
patients who came for follow-up.4
Study conducted by Homer JJ et al. of UK in December 2000
evaluated the effect of the tonicity of saline nasal douching solutions on
mucociliary clearance in order to ascertain whether hypertonicity conferred
any advantage. They conducted a randomized double-blind crossover trial.
Saline douching solutions of 0.9%, 3% and 5% tonicity were used and
mucociliary clearance were measured by the saccharin clearance time (SCT).
The resultant SCT after administration of 5% saline was significantly reduced
compared to both 0.9% (P = 0.005) and 3% saline (P = 0.04). Thus hypertonic
saline solutions improved mucociliary clearance.5
4
6.3
7.
7.2
Analysis of data will take 2 months, Typing and printing will also take 2
months. So, total duration of study will take 17 months.
Informed consent will be obtained from the patients
A) Inclusion criteria:
1. All cases of chronic sinusitis in the age group of 18 - 50 years will be
included.
2. Both sexes will be included.
B) Exclusion criteria:
1. Patients with known anatomical defect that obstructs the sinuses.
2. Patients with polyp and mucocele that obstructs the sinuses.
Sampling frame: All cases of chronic sinusitis attending the Department of
E.N.T (In patients and Out Patients) to all the units in S. Nijalingappa Medical
College and H. S. K Hospital and Research Centre, Bagalkot fulfilling the
eligibility criteria will be our sample size. Depending on last 2 years data from
medical records department expected sample size would be 60-80 patients.
Statistical analysis: Chi-Square test will be used to find the independence of
groups at 5% level of significance. Unpaired t test will be used to find
significant difference between the groups.
Study design: Single blind randomized comparative study
7.3
7.4
8.
List of References:
1.
2.
3.
from: URL:http://www.yoga-age.com/asanas/jala.pdf.
Shoseyov D, Bibi H, Shai P, Shoseyov N, Shazberg G and Hurvitz H.
9
Treatment with hypertonic saline versus normal saline nasal wash of pediatric
4.
5.
6.
7.
8.
9.
10.
11.
9.
10.
11.
11.1
11.2
Signature
11.3
11.4
Signature
11.5
12.
11.6
Signature
12.1
12.2
Signature
11
B. V. V. Sanghas
S. NIJALINGAPPA MEDICAL COLLEGE & H. S. K HOSPITAL & RESEARCH CENTRE,
NAVANAGAR, BAGALKOT 587102, KARNATAKA.
Department of E.N.T
ANNEXURE I
RESEARCH INFORMED CONSENT FORM
Study Title: RANDOMIZED COMPARATIVE STUDY TO EVALUATE EFFICACY OF
HYPERTONIC SALINE AGAINST ISOTONIC SALINE IN THE TREATMENT OF CHRONIC
SINUSITIS IN H. S. K HOSPITAL & RESEARCH CENTRE , BAGALKOT.
Principal Investigator/ PG Guides Name: Dr. Shereef Yahiya. M / Dr. Mallikarjun Reddy
Name of the subject:
Age/Sex:
1. I have been informed that this study requires use of Isotonic saline nasal drops / Hypertonic saline nasal
drops & the procedure may cause discomfort to the nose & throat.
2. I understand that my participation in the study may not have a direct benefit to me.
3. I understand that medical information produced by this study will become part of institutional record & will
be kept confidential by the said institute.
4. I understand that my participation is voluntary & may refuse to participate or may with draw my consent &
discontinue participation at any time without prejudice to my present or future care at this institution.
5. I agree not to restrict the use of any data or results that arise from this study provided such a use is only for
scientific purpose (s)
I confirm that
(Chief researcher/ Name of the PG
guide) has explained to me the purpose of research & the study procedure that I will undergo and the
possible risks & discomforts as well as benefits that I may experience, in my own language. Therefore I
agree to give consent to participate as a subject in this research project.
Participants signature
Date:
I have explained to
research, the possible risks and benefits to the best of my ability.
Date:
12